Immunomodulatory Activities of a Concentrated Fruit and Vegetable Juice Tested in a Randomized, Placebo-Controlled, Double-Blind Clinical Trial in Healthy Volunteers — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Immunomodulatory Activities of a Concentrated Fruit and Vegetable Juice Tested in a Randomized, Placebo-Controlled, Double-Blind Clinical Trial in Healthy Volunteers
22 healthy volunteers were included in a randomized, placebo-controlled pilot study in order to investigate immunomodulatory effects of a concentrated juice, containing the ingredients of a total of 80 different fruits, vegetables, herbs, mushrooms, oils, and others (Cellagon aurum ? , “CA”). 11 subjects received the concentrated juice while 11 were allocated to the placebo group. Stimulated whole-blood cultures were used to assess any treatment-related changes in the response of leukocytes towards experimental immune cell activation. For each of the individuals, 5 cultures were performed either immediately before, during, or 3 days after termination of the 7 weeks treatment. Leukocyte activities were determined by measuring cytokine levels in the supernatants at the end of the 48 h of stimulation (induced by the addition of LPS + SE-B + anti-CD28 antibodies). Despite the relatively small number of volunteers, multiplexed cytokine assays revealed a typical T-cell signature of cytokines that were increased significantly in the course of CA treatment compared to placebo (GM-CSF, IFN γ , IL-4, IL-10, IL-17, TNF β , all p < 0.05). These preliminary results suggest that CA is able to support leukocyte activation, in particular that of T-lymphocytes.
J. L. Rios, M. C. Recio, J. M. Escandell and I. Andujar, “Inhibition of Transcription Factors by Plant-Derived Compounds and Their Implications in Inflammation and Cancer,” Current Pharmaceutical Design, Vol. 15, No. 11, 2009, pp. 1212-1237. http://dx.doi.org/10.2174/138161209787846874
S. A. Stanner, J. Hughes, C. N. Kelly and J. Buttriss, “A Review of the Epidemiological Evidence for the ‘Antioxidant Hypothesis’,” Public Health Nutrition, Vol. 7, No. 3, 2004, pp. 407-422. http://dx.doi.org/10.1079/PHN2003543
M. Dell’Agli, C. Di Lorenzo, M. Badea, E. Sangiovanni, L. Dima, E. Bosisio and P. Restani, “Plant Food Supplements with Anti-Inflammatory Properties: A Systematic Review (I),” Critical Reviews in Food Science and Nutrition, Vol. 53, No. 4, 2013, pp. 403-413. http://dx.doi.org/10.1080/10408398.2012.682123
C. Di Lorenzo, M. Dell’agli, E. Colombo, E. Sangiovanni and P. Restani, “Metabolic Syndrome and Inflammation: A Critical Review of in Vitro and Clinical Approaches for Benefit Assessment of Plant Food Supplements,” Evidence-Based Complementary and Alternative Medicine, Vol. 2013, 2013, Article ID: 782461.
N. Iyer, S. A. Marathe, D. Chaudhuri, P. Garai and D. Chakravortty, “Immunomodulation Using Agonists and Antagonists: Potential Clinical Applications,” Expert Opinion on Investigational Drugs, Vol. 21, No. 1, 2012, pp. 67-81. http://dx.doi.org/10.1517/13543784.2012.642367
J. M. van Dieren, E. J. Kuipers, J. N. Samsom, E. E. Nieuwenhuis and C. J. van der Woude, “Revisiting the Immunomodulators Tacrolimus, Methotrexate, and Mycophenolate Mofetil: Their Mechanisms of Action and Role in the Treatment of IBD,” Inflammatory Bowel Diseases, Vol. 12, No. 4, 2006, pp. 311-327. http://dx.doi.org/10.1097/01.MIB.0000209787.19952.53
M. Ramadan, S. Goeters, B. Watzer, E. Krause, K. Lohmann, R. Bauer, B. Hempel and P. Imming, “Chamazulene Carboxylic Acid and Matricin: A Natural Profen and Its Natural Prodrug, Identified through Similarity to Synthetic Drug Substances,” Journal of Natural Products, Vol. 69, No. 7, 2006, pp. 1041-1045. http://dx.doi.org/10.1021/np0601556
V. M. Chandrashekhar, K. S. Halagali, R. B. Nidavani, M. H. Shalavadi, B. S. Biradar, D. Biswas and I. S. Muchchandi, “Anti-Allergic Activity of German Chamomile (Matricaria recutita L.) in Mast Cell Mediated Allergy Model,” Journal of Ethnopharmacology, Vol. 137, No. 1, 2011, pp. 336-340. http://dx.doi.org/10.1016/j.jep.2011.05.029
X. Gao, D. Deeb, Y. Liu, S. Gautam, S. A. Dulchavsky and S. C. Gautam, “Immunomodulatory Activity of Xanthohumol: Inhibition of T Cell Proliferation, Cell-Mediated Cytotoxicity and Th1 Cytokine Production through Suppression of NF-KappaB,” Immunopharmacology and Immunotoxicology, Vol. 31, No. 3, 2009, pp. 477-484. http://dx.doi.org/10.1080/08923970902798132
U. Svajger and M. Jeras, “Anti-Inflammatory Effects of Resveratrol and Its Potential Use in Therapy of Immune-Mediated Diseases,” International Reviews of Immunology, Vol. 31, No. 3, 2012, pp. 202-222. http://dx.doi.org/10.3109/08830185.2012.665108
J. H. Park, J. W. Kim, C. M. Lee, Y. D. Kim, S. W. Chung, I. D. Jung, K. T. Noh, J. W. Park, D. R. Heo, Y. K. Shin, J. K. Seo and Y. M. Park, “Sulforaphane Inhibits the Th2 Immune Response in Ovalbumin-Induced Asthma,” BMB Reports, Vol. 45, No. 5, 2012, pp. 311-316. http://dx.doi.org/10.5483/BMBRep.2012.45.5.311
Y. Zhang, D. Y. Leung, B. N. Richers, Y. Liu, L. K. Remigio, D. W. Riches and E. Goleva, “Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1,” Journal of Immunology, Vol. 188, No. 5, 2012, pp. 2127-2135. http://dx.doi.org/10.4049/jimmunol.1102412
J. M. Carcamo, O. Borquez-Ojeda and D. W. Golde, “Vitamin C Inhibits Granulocyte Macrophage-Colony-Stimulating Factor-Induced Signaling Pathways,” Blood, Vol. 99, No. 9, 2002, pp. 3205-3212. http://dx.doi.org/10.1182/blood.V99.9.3205
C. Hartel, T. Strunk, P. Bucsky and C. Schultz, “Effects of Vitamin C on Intracytoplasmic Cytokine Production in Human Whole Blood Monocytes and Lymphocytes,” Cytokine, Vol. 27, No. 4-5, 2004, pp. 101-106. http://dx.doi.org/10.1016/j.cyto.2004.02.004
J. J. Casciari, H. D. Riordan, N. Mikirova and J. Austin, “Effect of Vitamin C Supplementation on ex Vivo Immune Cell Functioning,” Journal of Orthomolecular Medicine, Vol. 18, No. 2, 2003, pp. 83-92.
J. Tamura, K. Kubota, H. Murakami, M. Sawamura, T. Matsushima, T. Tamura, T. Saitoh, H. Kurabayshi and T. Naruse, “Immunomodulation by Vitamin B12: Augmentation of CD8+ T Lymphocytes and Natural Killer (NK) Cell Activity in Vitamin B12-Deficient Patients by Methyl-B12 Treatment,” Clinical & Experimental Immunology, Vol. 116, No. 1, 1999, pp. 28-32. http://dx.doi.org/10.1046/j.1365-2249.1999.00870.x
H. K. Kwak, C. M. Hansen, J. E. Leklem, K. Hardin and T. D. Shultz, “Improved Vitamin B-6 Status Is Positively Related to Lymphocyte Proliferation in Young Women Consuming a Controlled Diet,” Journal of Nutrition, Vol. 132, No. 11, 2002, pp. 3308-3313.
S. C. Mueller, R. Marz, M. Schmolz and B. Drewelow, “Intraindividual Long Term Stability and Response Corridors of Cytokines in Healthy Volunteers Detected by a Standardized Whole-Blood Culture System for Bed-Side Application,” BMC Medical Research Methodology, Vol. 12, 2012, p. 112.
M. Triantafilou and K. Triantafilou, “Lipopolysaccharide Recognition: CD14, TLRs and the LPS-Activation Cluster,” Trends in Immunology, Vol. 23, No. 6, 2002, pp. 301-304. http://dx.doi.org/10.1016/S1471-4906(02)02233-0
T. Nagashima, T. Aranami, C. Iclozan and K. Onoé, “Analysis of T Cell Responses to a Superantigen, Staphylococcal Enterotoxin-B,” Journal of Clinical and Experimental Hematopathology, Vol. 44, No. 1, 2004, pp. 25-32. http://dx.doi.org/10.3960/jslrt.44.25
M. E. van Berkel and M. A. Oosterwegel, “CD28 and ICOS: Similar or Separate Costimulators of T Cells?” Immunology Letters, Vol. 105, No. 2, 2006, pp. 115-122. http://dx.doi.org/10.1016/j.imlet.2006.02.007
M. M. Wurfel, W. Y. Park, F. Radella, J. Ruzinski, A. Sandstrom, J. Strout, R. E. Bumgarner and T. R. Martin, “Identification of High and Low Responders to Lipopolysaccharide in Normal Subjects: An Unbiased Approach to Identify Modulators of Innate Immunity,” Journal of Immunology, Vol. 175, No. 4, 2005, pp. 2570-2578.
N. Serhan, “Resolvins and Protectins: Novel Lipid Mediators in Anti-Inflammation and Resolution,” Scandinavian Journal of Food and Nutrition, Vol. 50, No. S2, 2006, pp. 68-78. http://dx.doi.org/10.1080/17482970601066298
Z. Huang, A. H. Rose and P. R. Hoffmann, “The Role of selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities,” Antioxidants & Redox Signaling, Vol. 16, No. 7, 2012, pp. 705-743. http://dx.doi.org/10.1089/ars.2011.4145
G. Fortin, “L-Carnitine and Intestinal Inflammation,” Vitamins & Hormones, Vol. 86, 2011, pp. 353-366.
H. Haase and L. Rink, “Zinc Signals and Immune Function,” Biofactors, 2013.
A. M. Sullivan, J. G. Laba, J. A. Moore and T. D. Lee, “Echinacea-Induced Macrophage Activation,” Immunopharmacology and Immunotoxicology, Vol. 30, No. 3, 2008, pp. 553-574. http://dx.doi.org/10.1080/08923970802135534
M. R. Ritchie, J. Gertsch, P. Klein and R. Schoop, “Effects of Echinaforce (R) Treatment on ex Vivo-Stimulated Blood Cells,” Phytomedicine, Vol. 18, No. 10, 2011, pp. 826-831. http://dx.doi.org/10.1016/j.phymed.2011.05.011
A. P. Moreira, T. F. Texeira, A. B. Ferreira, C. Peluzio Mdo and C. Alfenas Rde, “Influence of a High-Fat Diet on Gut Microbiota, Intestinal Permeability and Metabolic Endotoxaemia,” British Journal of Nutrition, Vol. 108, No. 5, 2012, pp. 801-809. http://dx.doi.org/10.1017/S0007114512001213
N. D. Pugh, C. R. Jackson and D. S. Pasco, “Total Bacterial Load within Echinacea Purpurea, Determined Using a New PCR-Based Quantification Method, Is Correlated with LPS Levels and in Vitro Macrophage Activity,” Planta Medica, Vol. 79, No. 1, 2013, pp. 9-14.
T. R. Mosmann and S. Sad, “The Expanding Universe of T-Cell Subsets: Th1, Th2 and More,” Immunology Today, Vol. 17, No. 3, 1996, pp. 138-146. http://dx.doi.org/10.1016/0167-5699(96)80606-2
E. Maier, A. Duschl and J. Horejs-Hoeck, “STAT6-Dependent and -Independent Mechanisms in Th2 Polarization,” European Journal of Immunology, Vol. 42, No. 11, 2012, pp. 2827-2833. http://dx.doi.org/10.1002/eji.201242433
T. L. Geiger and S. Tauro, “Nature and Nurture in Foxp3(+) Regulatory T Cell Development, Stability, and Function,” Human Immunology, Vol. 73, No. 3, 2012, pp. 232-239. http://dx.doi.org/10.1016/j.humimm.2011.12.012
S. O. Yoon, X. Zhang, P. Berner and Y. S. Choi, “IL-21 and IL-10 Have Redundant Roles but Differential Capacities at Different Stages of Plasma Cell Generation from Human Germinal Center B Cells,” Journal of Leukocyte Biology, Vol. 86, No. 6, 2009, pp. 1311-1318. http://dx.doi.org/10.1189/jlb.0409268